Chemours Co
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.8% | -3.3% | -9.1% | +3.0% | +0.7% | -1.6% | +1.3% | +1.1% | -2.5% | -1.6% | -1.6% | |
| – | +4.1% | -6.2% | -18.3% | +4.9% | -1.8% | -3.1% | +5.7% | +3.5% | -6.4% | -2.4% | +5.7% | |
| – | +41.2% | -38.0% | -19.0% | -1.3% | +19.6% | -34.9% | +8.2% | +22.1% | +9.3% | -16.0% | +19.2% | |
| – | +41.2% | -38.0% | -19.0% | -1.3% | +19.6% | -34.9% | +8.2% | +22.1% | +9.3% | -16.0% | +19.2% | |
| – | -27.9% | +29.8% | +13.1% | +6.1% | -19.0% | +11.4% | +11.8% | -1.3% | -28.3% | +11.8% | +19.5% | |
| – | +2.9% | +2.9% | -1.7% | +5.1% | +2.4% | +5.3% | +0.5% | -0.7% | +1.4% | -2.1% | -5.5% | |
| – | – | – | – | – | +0.4% | -0.7% | -0.4% | -0.9% | -0.7% | – | – | |
| – | +0.0% | +0.0% | +0.0% | -54.9% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -40.0% | +0.0% | +0.0% | +0.0% | +0.0% | -33.3% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +4.5% | -3.8% | -9.7% | +4.3% | +1.6% | -1.4% | +6.4% | +0.3% | -1.9% | -1.1% | +2.1% | |
| – | +13.3% | -10.3% | -30.2% | +14.1% | +1.5% | -7.2% | +10.6% | +1.6% | -10.3% | -4.6% | +15.7% | |
| – | +35.9% | -11.3% | -4.3% | +17.8% | +0.9% | -2.8% | -4.8% | +15.2% | -8.8% | -4.8% | -8.1% | |
| – | +29.2% | -17.2% | -3.0% | +13.8% | +8.0% | -12.7% | +1.7% | +1.2% | -7.7% | -7.1% | +5.1% | |
| – | +1.1% | -0.5% | -0.4% | +0.9% | +1.7% | +0.2% | +0.9% | -0.1% | +0.0% | +0.0% | -6.4% | |
| – | -2.4% | +2.0% | -3.9% | -9.1% | -8.1% | -4.1% | -59.1% | +25.7% | -16.1% | -14.0% | -122.8% | |
| – | -3.4% | +0.8% | +1.7% | -3.6% | -2.6% | -3.4% | -23.7% | +3.7% | -7.0% | -3.4% | -24.4% | |
| – | -1.1% | +1.0% | +0.0% | -0.3% | +0.1% | +0.4% | -0.1% | +0.0% | +0.2% | +0.0% | +0.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.